News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Lone Star Bio
Asuragen, Inc.'s microRNA Expression Profiling Service Offers Sanger miRBase 8.0 Plus New Proprietary Content; Enhanced Service Offering Will Expand The Number Of microRNAs That Can Be Globally Analyzed For Differential Gene Expression
August 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Asuragen announces the launch of the next generation of microarray content to be offered through its microRNA Expression Profiling Service.
Twitter
LinkedIn
Facebook
Email
Print
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
·
3 min read
·
Greg Slabodkin
Business
Merck KGaA, Caris Sign Potential $1.4B Deal to Develop First-in-Class ADCs for Cancer
April 4, 2024
·
2 min read
·
Tyler Patchen
Drug Development
Biotech Accelerator Debuts in Houston
October 18, 2023
·
3 min read
·
Charlotte LoBuono
